PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
4.87%
Positive growth while Healthcare median is negative. Peter Lynch would examine competitive advantages in a declining market.
3.10%
Cost increase while Healthcare shows cost reduction. Peter Lynch would examine competitive disadvantages.
12.17%
Growth of 12.17% versus flat Healthcare gross profit. Walter Schloss would verify quality.
6.96%
Margin change of 6.96% versus flat Healthcare margins. Walter Schloss would verify quality.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
G&A reduction while Healthcare median is 0.00%. Seth Klarman would investigate efficiency gains.
-100.00%
Marketing expense reduction while Healthcare median is 0.00%. Seth Klarman would investigate competitive implications.
-100.00%
Other expenses reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
5.14%
Operating expenses growth while Healthcare reduces costs. Peter Lynch would examine differences.
3.45%
Total costs growth while Healthcare reduces costs. Peter Lynch would examine differences.
6.52%
Interest expense change of 6.52% versus flat Healthcare costs. Walter Schloss would verify control.
-4.37%
D&A reduction while Healthcare median is 0.00%. Seth Klarman would investigate efficiency.
121.19%
EBITDA growth exceeding 1.5x Healthcare median of 5.14%. Joel Greenblatt would investigate advantages.
110.92%
Margin change of 110.92% versus flat Healthcare. Walter Schloss would verify quality.
49.18%
Operating income growth exceeding 1.5x Healthcare median of 3.75%. Joel Greenblatt would investigate advantages.
42.25%
Margin change of 42.25% versus flat Healthcare. Walter Schloss would verify quality.
3364.29%
Other expenses change of 3364.29% versus flat Healthcare. Walter Schloss would verify control.
55.15%
Pre-tax income growth exceeding 1.5x Healthcare median of 7.01%. Joel Greenblatt would investigate advantages.
47.94%
Margin change of 47.94% versus flat Healthcare. Walter Schloss would verify quality.
475.92%
Tax expense change of 475.92% versus flat Healthcare. Walter Schloss would verify strategy.
14.74%
Net income growth exceeding 1.5x Healthcare median of 5.10%. Joel Greenblatt would investigate advantages.
9.41%
Margin change of 9.41% versus flat Healthcare. Walter Schloss would verify quality.
14.74%
EPS growth exceeding 1.5x Healthcare median of 9.26%. Joel Greenblatt would investigate advantages.
14.74%
Diluted EPS growth exceeding 1.5x Healthcare median of 9.09%. Joel Greenblatt would investigate advantages.
-0.00%
Share count reduction while Healthcare median is 0.23%. Seth Klarman would investigate strategy.
-0.00%
Diluted share reduction while Healthcare median is 0.29%. Seth Klarman would investigate strategy.